[{"Assets_0_Q3_USD":"2640067000.0","CIK":"874716","CommonStockSharesIssued_0_Q3_shares":"107095000.0","CommonStockSharesOutstanding_0_Q3_shares":"82995000.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"2.17","EarningsPerShareBasic_3_Q3_USD":"6.04","EarningsPerShareDiluted_1_Q3_USD":"2.15","EarningsPerShareDiluted_3_Q3_USD":"5.97","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"42180715521.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"369556000.0","NetIncomeLoss_1_Q3_USD":"180938000.0","NetIncomeLoss_3_Q3_USD":"506882000.0","OfficialName":"IDEXX Laboratories Inc. Common Stock","ProfitLoss_1_Q3_USD":"180938000.0","ProfitLoss_3_Q3_USD":"506882000.0","RevenuesConverted_1_Q3_USD":"841661000.0","RevenuesConverted_3_Q3_USD":"2538756000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":"475999000.0","StockholdersEquity_0_Q3_USD":"475999000.0","Ticker":"IDXX","TreasuryStockSharesConverted_0_Q3_shares":"24101000.0","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"84113000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"84858000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"83247000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"83855000.0","filed":"20221101","footnote":null,"form":"10-Q","fp":"Q3","fy":"2022.0","name":"IDEXX LABORATORIES INC \/DE","period":"20220930","qtrs":"0","uom":"USD"}]